Form 4: Paychex CEO John B. Gibson Reports Significant Equity Transactions
Insider Transaction Report
Paychex Inc.'s President and CEO, John B. Gibson, reported the acquisition of restricted stock units and stock options, alongside the disposition of shares for tax obligations and a sale of common stock.
Summary
- John B. Gibson, President and CEO of Paychex Inc. (PAYX), reported multiple equity transactions.
- On July 15, 2025, Gibson disposed of 16,585 shares of common stock at $140.68 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- On the same date, Gibson was awarded 21,175 restricted stock units (RSUs) and an additional 9,063 restricted stock units, both subject to vesting and granted under the Amended and Restated 2002 Stock Incentive Plan, with an acquisition price of $0.
- Also on July 15, 2025, Gibson acquired 62,758 stock options with an exercise price of $140.68, exercisable from July 15, 2026, and expiring on July 14, 2035.
- On July 16, 2025, Gibson sold 12,370 shares of common stock at $141.92 per share.
- Following these transactions, Gibson's direct beneficial ownership of common stock was 81,755 shares, and he held 62,758 new stock options, in addition to previously held options.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. While there are share dispositions (one for tax, one a sale), these are offset by significant awards of restricted stock units and new stock options, indicating ongoing executive compensation and alignment with long-term company performance. The transactions appear to be largely pre-planned under a 10b5-1 plan, which reduces their immediate market signaling impact.
Positives
- Award of 21,175 restricted stock units and 9,063 restricted stock units, totaling 30,238 shares, indicating continued equity-based compensation and alignment with shareholder interests.
- Grant of 62,758 stock options, providing future potential upside tied to company performance.
Negatives
- Disposition of 16,585 shares to satisfy tax withholding obligations, which is a common but non-discretionary reduction in direct holdings.
- Sale of 12,370 shares of common stock, representing a reduction in direct ownership.
Future Outlook
NA
Industry Context
This Form 4 filing details routine insider equity transactions for the President and CEO of Paychex Inc., a leading provider of human capital management solutions. Such filings are standard disclosures for executive compensation and personal investment activities, and do not typically reflect broader industry trends or competitive positioning.
Related Party Transactions
- Disposition of 16,585 shares of common stock by John B. Gibson, President and CEO, to satisfy tax withholding obligations related to restricted stock unit vesting.
- Award of 21,175 restricted stock units and 9,063 restricted stock units to John B. Gibson under the company's Amended and Restated 2002 Stock Incentive Plan.
- Acquisition of 62,758 stock options by John B. Gibson.
- Sale of 12,370 shares of common stock by John B. Gibson.
Stakeholder Impact
- Shareholders: The transactions represent routine executive compensation and personal investment activity. The awards of RSUs and stock options align management's interests with long-term shareholder value. The sales are typical for liquidity or tax purposes.
- Employees: No direct impact on general employees is indicated.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.
Key Dates
| Date | Description |
|---|---|
| 07/11/2019 | Date exercisable for a stock option with an exercise price of $69.54. |
| 07/10/2020 | Date exercisable for a stock option with an exercise price of $85.46. |
| 07/15/2021 | Date exercisable for a stock option with an exercise price of $73.53. |
| 07/15/2022 | Date exercisable for a stock option with an exercise price of $112.67. |
| 01/15/2023 | Date exercisable for a stock option with an exercise price of $125. |
| 07/15/2023 | Date exercisable for a stock option with an exercise price of $115. |
| 10/15/2023 | Date exercisable for a stock option with an exercise price of $109.19. |
| 07/15/2024 | Date exercisable for a stock option with an exercise price of $120.86. |
| 07/15/2025 | Date of disposition of shares for tax withholding, award of restricted stock units, and acquisition of new stock options. |
| 07/16/2025 | Date of common stock sale. |
| 07/17/2025 | Signature date of the reporting person's attorney-in-fact. |
| 07/15/2026 | Date exercisable for newly acquired stock options with an exercise price of $140.68. |
| 07/10/2028 | Expiration date for a stock option with an exercise price of $69.54. |
| 07/09/2029 | Expiration date for a stock option with an exercise price of $85.46. |
| 07/14/2030 | Expiration date for a stock option with an exercise price of $73.53. |
| 07/14/2031 | Expiration date for a stock option with an exercise price of $112.67. |
| 01/14/2032 | Expiration date for a stock option with an exercise price of $125. |
| 07/14/2032 | Expiration date for a stock option with an exercise price of $115. |
| 10/14/2032 | Expiration date for a stock option with an exercise price of $109.19. |
| 07/14/2033 | Expiration date for a stock option with an exercise price of $120.86. |
| 07/14/2034 | Expiration date for a stock option with an exercise price of $121.63. |
| 07/14/2035 | Expiration date for newly acquired stock options with an exercise price of $140.68. |
Recommendation
holdKeywords
Paychex Inc., PAYX, SEC Form 4, Insider Trading, Stock Options, Restricted Stock Units, Equity Compensation, John B. Gibson, CEO, Share Disposition, Share Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.